相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug-drug cocrystals: Opportunities and challenges
Xiaojuan Wang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Co-Crystal Structures of Furosemide:Urea and Carbamazepine:Indomethacin Determined from Powder X-Ray Diffraction Data
Okba Al Rahal et al.
CRYSTALS (2020)
Melting points of one- and two-component molecular crystals as effective characteristics for rational design of pharmaceutical systems
German Perlovich
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS (2020)
Enhancing the solubility and permeability of the diuretic drug furosemide via forms
Luan F. Diniz et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Interconvertible Hydrochlorothiazide-Caffeine Multicomponent Pharmaceutical Materials: A Solvent Issue
Cristobal Verdugo-Escamilla et al.
CRYSTALS (2020)
Drug-drug cocrystals of anticancer drugs erlotinib-furosemide and gefitinib-mefenamic acid for alternative multi-drug treatment
Christy P. George et al.
CRYSTENGCOMM (2020)
Furosemide:Triethanolamine Salt as a Strategy To Improve the Biopharmaceutical Properties and Photostability of the Drug
Julieta Abraham Miranda et al.
CRYSTAL GROWTH & DESIGN (2019)
Trimorphic Ethenzamide Cocrystal: In Vitro Solubility and Membrane Efflux Studies
Rajiv Khatioda et al.
CRYSTAL GROWTH & DESIGN (2018)
TOPAS and TOPAS-Academic: an optimization program integrating computer algebra and crystallographic objects written in C plus
Alan A. Coelho
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2018)
Triamterene-furosemide salt: structural aspects and physicochemical evaluation
Bo Peng et al.
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS (2018)
A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals
Arun Kumar et al.
ADVANCED PHARMACEUTICAL BULLETIN (2018)
Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design
David J. Berry et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Salts and Cocrystals of Furosemide with Pyridines: Differences in π-Stacking and Color Polymorphism
Ekta Sangtani et al.
CRYSTAL GROWTH & DESIGN (2017)
Cocrystal and Salt Forms of Furosemide: Solubility and Diffusion Variations
Manas Banik et al.
CRYSTAL GROWTH & DESIGN (2016)
Furosemide
Laura Carone et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)
Furosemide Cocrystals with Pyridines: An Interesting Case of Color Cocrystal Polymorphism
Ekta Sangtani et al.
CRYSTAL GROWTH & DESIGN (2015)
Drug-Drug Molecular Salt Hydrate of an Anticancer Drug Gefitinib and a Loop Diuretic Drug Furosemide: An Alternative for Multidrug Treatment
Shridhar H. Thorat et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering
Christoph Loschen et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2015)
Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs
Nicholas Moore et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
SHELXT - Integrated space-group and crystal-structure determination
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2015)
Crystal structure refinement with SHELXL
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2015)
A robust two-dimensional hydrogen-bonded network for the predictable assembly of ternary co-crystals of furosemide
Vijay K. Srirambhatla et al.
CRYSTENGCOMM (2014)
Mechanochemical preparation of co-crystals
Dario Braga et al.
CHEMICAL SOCIETY REVIEWS (2013)
Synthon identification in co-crystals and polymorphs with IR spectroscopy. Primary amides as a case study
Arijit Mukherjee et al.
CRYSTENGCOMM (2013)
New Crystalline Forms of Piroxicam
Anatoly Mishnev et al.
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES (2013)
Multicomponent pharmaceutical cocrystals: furosemide and pentoxifylline
Dmitrijs Stepanovs et al.
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2012)
Polymorphs and a Hydrate of Furosemide-Nicotinamide 1:1 Cocrystal
Takamitsu Ueto et al.
CRYSTAL GROWTH & DESIGN (2012)
The role of mechanochemistry and supramolecular design in the development of pharmaceutical materials
Amit Delori et al.
CRYSTENGCOMM (2012)
Novel furosemide cocrystals and selection of high solubility drug forms
N. Rajesh Goud et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation
Yuriy A. Abramov et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Randomized, open-label, 5-way crossover study to evaluate the pharmacokinetic/pharmacodynamic interaction between furosemide and the non-steroidal anti-inflammatory drugs diclofenac and ibuprofen in healthy volunteers
C. A. Paterson et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Conformational and Synthon Polymorphism in Furosemide (Lasix)
N. Jagadeesh Babu et al.
CRYSTAL GROWTH & DESIGN (2010)
Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy
Andrea Heinz et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Structure validation in chemical crystallography
Anthony L. Spek
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
Discovering New Co-Crystals
J. H. ter Horst et al.
CRYSTAL GROWTH & DESIGN (2009)
Pharmaceutical Cocrystals and Their Physicochemical Properties
Nate Schultheiss et al.
CRYSTAL GROWTH & DESIGN (2009)
The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome
Tomislav Friscic et al.
CRYSTENGCOMM (2009)
OLEX2: a complete structure solution, refinement and analysis program
Oleg V. Dolomanov et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Mercury CSD 2.0 -: new features for the visualization and investigation of crystal structures
Clare F. Macrae et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2008)
The Cambridge Structural Database: a quarter of a million crystal structures and rising
FH Allen
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE (2002)
分享论文
